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Feature Articles

AIDS Update
Evelyn J. Fisher, MD*

he acquired immunodeficiency syndrome (AIDS) vims is
now called the human immunodeficiency vims (HIV). By
attacking the immune and nervous systems, HIV causes a broad
range of disease ranging from none to fatal. The fatal illness
AIDS represents end-stage disease of the immune system. However, at any given time for every one person with the fatal illness
there may be 50 to IOO infected people who have no or milder
illness.
The manifestations of HIV infection are both primary, those
due directly to the virus itself, and secondary, those due to
immune damage. The secondary manifestations were the first
recognized and are characteristic of immune deficiencies in
general. These are: I) infections, including opportunistic infections; 2) tumors, including certain "opportunistic" tumors such
as Kaposi's sarcoma and lymphomas (both of which also occur
in transplant patients); and 3) other phenomena of immune
dysregulation including autoimmune phenomena, of which
thrombocytopenic purpura is the most common. The primary
manifestations of HIV infection have been recognized only
recently, and it is likely that more remain to be defined. Two
well-recognized manifestations are 1) an acute infectious-mononucleosis-Iike illness that occurs within one to eight weeks of
initial infection, and 2) a spectrum of neurological illness.
Neurologic symptoms may occur as an acute transient process
shortly after infection or at any time during the course of the disease. Other manifestations that may prove to be due to HIV itself
include interstitial pneumonia and gastrointestinal disorders,
particularly diarrhea.HIV has been shown to infect certain cells
in the body—the T-helper lymphocytes, the monocyte/macrophages, and some central nervous system cells. It is not clear
to what extent other cells in the body are infected, such as
B-lymphocytes and intestinal cells. There is a recent description
of in vitro infection of primary colonic epithelium.
The HIV attack on the immune system is especially devastating because it strikes the "commander" of the immune system,
the T-helper lymphocyte, as well as "frontline troops," the
monocytes/macrophages, which are the antigen-processing and
presenting cells. Since the T-helper lymphocyte controls at least
six other reactions in the immune system, including most B-cell
function, immune deficiency due to HIV involves much more
than cell-mediated immunity. Thus HIV can cause immune deficiency more profound than that of any other acquired form of
immune deficiency and is comparable only to that of congenital
severe combined immunodeficiency (SCID). Unlike SCID,
however, one cannot save AIDS patients by shielding them in a
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"bubble" because they already have acquired the latent opportunistic pathogens that will kill them. Bone marrow transplantation has yet to be successful in AIDS.

Virology
Retroviruses, the family to which the AIDS virus belongs,
are RNA viruses. They make a DNA copy of themselves by a
unique enzyme, reverse transcriptase. This DNA copy, the
provirus, inserts itself (ie, becomes integrated) into the chromosomes of certain host cells; thus, infection is generally lifelong. Retroviruses can cause a range of effects: none, latent
infection, cell damage, malignant transformation, or cell death.
Retroviruses produce proteins that are transaciivating. These
iransactivating factors can affect the function of adjacenl and
distant genes on the chromosome at the level of bolh transcription (the making of RNA from DNA) and translation (the making of proteins from RNA). Transactivaling factors can increase
the activity of other genes by a thousandfold or more. In fact,
retroviral Iransactivating factors are being used to study the gene
products of many different cells.
Relrovimses are divided into three groups: the oncovimses
(tumor-producing), the lentiviruses (slow viruses), and the
spumaviruses (foamy viruses). HIV belongs to the second
group, the lentiviruses. The first recognized human retroviruses, HTLV-I and HTLV-II, as well as most known animal
retroviruses (starting wilh Rous' sarcoma described in 19n) are
oncovimses—that is, they directly produce malignant transformation of infected cells. On the other hand, HIV is not itself
oncogenic. The malignancies characteristic of AIDS probably
result from other common vimses acting "opportunistically"
oncogenic due to the immune deficiency. For example, the Bcell lymphomas which occur in AIDS (and transplant patients)
are probably caused by the Epstein-Barr virus. Kaposi's sarcoma may possibly be due to cytomegalovims.
In a sense, the lentivimses are worse than the oncovimses.
The prototype of the lentivims group is visna, a neurologic disease of sheep. Despite the economic importance of this infection, efforts to develop a vaccine have failed for over a decade.
The visna virus constantly modifies its antigens thus eluding the
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host immune system. In this respect HIV closely resembles the
visna vims, which implies similar difficulties in developing a
HIV vaccine. The only successful retroviral vaccine developed
to date is for an oncovims, that of feline leukemia. Feline leukemia is different from HIV disease in that some cats develop a
natural immunity to this disease. It is unlikely that a vaccine or
cure for HIV infection will be developed in less than five to ten
years and it could take 20 or more years. Because the HIV DNA
provirus becomes part of the genome of lymphocytes, monocytes, and perhaps other cells, tme cure requires the ability to
excise parts of human DNA.
AIDS is a disease that is going to be with us for a generation or
more. Most Americans will never catch HIV, but most will
come to have personal experience with the disease through
someone they know—a family member, friend, or co-worker.
No health care worker will be able to avoid caring for HIV-infected persons. HIV infection will saturate those populations
where people continue high-risk behavior and where infection
rates are already very high—certain homosexual/bisexual men
and intravenous dmg abusers. The infection will spread, probably more slowly but inexorably, as a sexually transmitted disease in the general heterosexual population. The challenge is to
curtail its spread and control the accompanying epidemic as
well, that of AIDS hysteria.

AIDS Hysteria
AIDS hysteria is as alarming as AIDS itself. Unfortunately,
AIDS hysteria is still socially acceptable in our country, while
hysterical behavior in any other potentially life-threatening situation is not. Even many health care professionals regard it as
"reasonable" to refuse to treat AIDS patients. The first step in
combating hysteria is to understand how HIV may have originated. Diabolical as HIV seems, it appears to be just another one
of Mother Nature's nasty tricks.
The current best hypothesis is that HIV arose perhaps 30 to 40
years ago in central Africa from a mutation of a very similar simian vims, STLV-III. The STLV-III vims is found in the African
Green monkey which associates closely with man and is killed
by man for food. The most likely route of transmission to man
may have been through skin cuts during the butchering process.
In Africa infection may have originated as a rare mral disease;
then, through population shifts, it became what it is today, a
common urban disease.
The next step in tackling AIDS hysteria is to acknowledge two
very deep-seated irrational fears of man: the fear of contagion
and the fear of homosexuality. Because of personal experience
with highly contagious infections like the common cold and the
history of epidemics of influenza, smallpox, and plague, most
people believe that all infections are easy to catch, and they fear
being around anyone with an infection of any kind. It is very
difficult to convince people that some infections, such as HIV,
are very difficult to catch.
Homophobia, the fear of and prejudice against homosexuality, is prevalent in our society. Yet sexual preference seems to
be acquired at a very early age, may even be genetic, and almost
never can be changed. About 10% of our fellow humans are
homosexual or bisexual. This includes 10% of our sons, grand-
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sons, brothers, and male friends and co-workers. Nevertheless,
homosexuality is still taboo and illegal in most areas. The homosexuality of one's own sex is more threatening than that of the
opposite sex. Thus heterosexual males may have more difficulty
in dealing with AIDS. Unconsciously, men may feel that showing any interest in HIV disease or placing themselves at the
slightest risk of catching it might make some people think that
they are homosexual. Often the husbands and boyfriends of
female health care workers will strongly object to their working
with AIDS patients and will insist that the women wash and
change clothes completely before coming home.
The dangers of letting hysteria remain unchecked are underappreciated by most people who are unaware of the barbaric
outcome of uncontrolled social and religious hysteria in human
history. The idea that disease is God's punishment is a powerful
and pervasive human belief. Two theories are commonly invoked. The first theory is that the disease, such as AIDS, is
God's punishment on a certain individual for his or her sins.
This theory does not explain 1) the infection of "innocent victims" such as children, or 2) why both heterosexuals and male
homosexuals are affected and lesbians are not. The second theory is much more dangerous: the disease is God's punishment on
all of us because of the sins of some of us (those "some" being
"sinners" and "heretics"). This is the theory that has led in the
past to mass murder. For example, during plague epidemics in
the Middle Ages the common response was for Christians to
slaughter Jews in the belief that the presence of these heretics
had angered God and caused Him to bring the disease upon
everyone. The Spanish Inquisition carried this concept of eradication of heretics to its extreme, but was not successful in
ridding Spain of disease.
Hysteria is harmful because it wastes tremendous amounts of
time, money, and energy which are needed to fight the real
epidemic of AIDS. The medical consequences of this hy.steria
include 1) shortage of blood donations (the number of blood donations is still significantly less than before AIDS, since people
still wrongly believe that AIDS can be acquired by giving
blood); 2) undemse of the valuable hepatitis B vaccine; and 3)
refusal of patients to accept necessary blood transfusions. Incalculable is the amount of unnecessary emotional stress on both
patients and staff that is caused by this hysteria.
The final step in dealing with hysteria is for people to be receptive to the actual data on transmission of HIV. The public as
well as medical personnel still have many misconceptions regarding HIV transmission. There is confusion over the incubation period and unfamiliarity with transmission data regarding
the large numbers of household contacts and health care workers
who have been studied and who have tested negative for HIV.

AIDS Incubation
Confusion over the incubation period is understandable since
there are actually five incubation periods which are pertinent to
HIV infection. They involve the time from becoming infected
with HIV to 1) viremia and potential contagiousness, 2) antibody (test) positivity, 3) acute illness, 4) symptoms of any kind,
and 5) AIDS itself. A common misconception is to mistake incubation period #5 for #2; that is, many think that it will take
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five years to detect if anyone has been infected with the AIDS
vims after being exposed to it, but actually the antibody test provides the information usually within three months of exposure.
Our current knowledge of these incubation periods suggests the
following time table:
1. Time to viremia (hence potential contagiousness through
blood and sex): one to three weeks.
2. Time to antibody positivity (time for the blood test to
become positive): usually between two to three months, occasionally longer, possibly up to six to 12 months.
3. Time between infection and the transient acute illness
(which may be infectious-mononucleosis-like or neurologic):
one to eight weeks.
4. Time to development of any sort of symptoms: one week to
indefinitely.
5. Time to development of full-blown AIDS (fatal disease):
six months to seven or more years, averaging five or more years
in adults; zero (birth) to seven years in perinatal infection, averaging one and one-half to two years in infants.
The last incubation period, the time to development of fatal
disease, is probably still being underestimated. HIV infection is
lifelong in most persons, and it appears that the risk of fatal disease exists throughout the life of the infected person. We do not
know what percent of infected people will eventually develop
AIDS, but it may be a large percentage, perhaps as many as 50%
or more by ten years after infection and an unknown percent
beyond that time.

TVansmission of AIDS
Sexual relations
HIV infection is in nature a sexually transmitted disease of
human beings. There is nothing unique about homosexuality
and this disease. In Africa the disease is a widespread heterosexual infection. Through some capricious set of circumstances,
the first persons infected in the United States were homosexual
men. HIV is present in semen, vaginal, and cervical secretions.
The virus is frequently transmitted by heterosexual or male
homosexual relations, but lesbian transmission is extremely rare
with only two possible cases reported. It is likely that male-tofemale transmission is more effective than female-to-male
transmission. The risk of transmission appears to be very high
during anal intercourse, fairly high during vaginal intercourse,
and fairly low during oral intercourse. Because the rectal lining
is more delicate than that of the vagina or mouth and tears and
bleeds more easily, infection inoculated in the rectal lining
seems more likely to have direct access to the bloodstream. An
additional factor that may increase risk of anal infection is that
semen itself is immunosuppressive if it reaches the bloodstream.
Fortunately, AIDS is less readily transmitted sexually than
many other sexually transmitted diseases. Some people can be
exposed many times and still not contract the infection. However, some people do become infected after only one or two episodes of coitus. These differences in susceptibility among
exposed persons probably relate to three factors: 1) degree of
infectiousness of the carrier, 2) general state of health of the
exposed persons (including other concurrent infections), and
3) genetic susceptibility of the exposed person. These factors are
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probably very important in determining the likelihood of infection when the exposure is to relatively low doses of vims, such
as by sexual contact and needle stick. On the other hand, when
the exposure is to large doses of vims injected directly into the
bloodstream, ie, when an infected unit of blood is received,
almost no one is resistant to infection.
Heterosexual relations
Regarding heterosexual transmission, in the United States
women represent only 7% of AIDS cases, and half of these
women are infected from intravenous drug abuse, not sexual
relations. In central Africa women comprise 50% of the cases,
and transmission is almost all sexual.
In urban areas of central Africa 20% to 88% of female prostitutes are infected with HIV heterosexually. However, in the
United States and Europe, most prostitutes become infected
from intravenous dmg abuse, since the pool of infected heterosexual men is very small outside the dmg abusing population.
Street prostitute infection rates of 13% in Detroit and 58% in
Newark, New Jersey, where there are large numbers of infected
dmg abusers, are not surprising. There has been to date in the
United States what would seem to be less cases than expected
among male customers of female prostitutes. Possible reasons
for this include health and genetic factors, a lower risk of
female-to-male transmission, and the American male's frequent
preference for fellatio. (In Africa sex with prostitutes virtually
always involves vaginal intercourse.)
The risk of male-to-female transmission as measured by the
rate of seropositives among steady female partners of infected
males has ranged from 7% to 70% in various studies. Interestingly, analyses of these studies show that the men fall into two
groups: one with a high transmission rate of 40% to 70%, and
the other with a low rate of 7% to 30% transmission to female
partners. The high-transmission group includes men who are 1)
intravenous drug abusers; 2) heterosexual armed forces men
(who often have acquired the infection from many prostitute
contacts); or 3) African or Haitian men. The low-transmission
group includes men who are 1) hemophiliacs, 2) other transfusion recipients, or 3) bisexual. In attempting to explain this
discrepancy in risk of transmission to female partners, one hypothesis is that the high-transmission group can be characterized
by a high incidence of other sexually transmitted diseases and/or
malnutrition or poverty. Whether such a hypothesis is valid is
unknown. Of concern is that these factors that may lead to a
higher transmission rate are characteristic of our urban poor.
The rapid heterosexual spread of HIV in Africa is alarming:
infection rates of mothers at a well-baby clinic in Zaire increased
from 1% in 1980 to 5% in 1985 and in prostitutes in Nairobi from
8% in 1981 to 85% in 1987. Two factors in Africa could accelerate the heterosexual spread: 1) malnutrition and malaria may
weaken the immune system, making persons more susceptible
to HIV; and 2) the current raging epidemic of other sexually
transmitted diseases in Africa may giveriseto conditions in the
genitalia that make an individual both more infectious and more
susceptible to HIV. Several recent studies suggest that the presence of genital ulcer disease increases HIV transmission. In
Africa, chancroid is very common, as well as herpes and syphilis, as a cause of genital ulcers. Even inflammation of the geni-
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tai mucosa due to gonococcal or chlamydial infection may make
the mucosa more permeable to HIV and lead to an outpouring
of inflammatory cells, including the lymphocytes and monocytes which are the primary cells that are HIV-infected and
HIV-infectible.
A recent preliminary report from Britain suggests increased
likelihood of HIV infection and progression of HIV disease in
persons carrying one of the three alleles of group specific component (Gc factor, which is the vitamin D receptor present in
blood and on the surface of cells). Population studies have
shown that the proportion of persons heterozygous or homozygous for the unfavorable allele is around 15% in whites in
Europe and the United States versus 60% in blacks in Africa.
This raises the very alarming possibility that blacks could be
more susceptible to HIV on a genetic basis.
Another recently described variable that may influence het
erosexual (and presumably homosexual) transmission of HIV is
the level of immune function of the infected person. Transmis
sion appears greater when immune function is lower, possibly
due to higher titers of vims in blood and presumably semen. In
studies by Redfield et al among seropositive heterosexuals in the
armed forces (almost all male), the percentage of spouses who
were seropositive was 16% (3/19) when the index case had a nor
mal number of T-helper cells ( > 400/|xL), 25% (2/8) when the
number of T-helper cells was below 400 but AIDS-related com
plex (ARC) or AIDS were not present, and 56% (13/25) when
ARC (as indicated by thmsh) or AIDS were present. This finding has potentially ominous implications. To date, among hemophiliacs and even bisexual men, very few spouses and almost
no children have been infected. Most infected children in the
United States are offspring of intravenous drug abusers. This
low incidence of infection in spouses and children of hemophiliacs and bisexual men could change over the next five years.
Since most infected persons show a decline in immune function
over time, these men may become more infectious to their
spouses. Also, pregnant women may be more likely to transmit
HIV to the fetus if their immune function is low.
Blood transniission
Transmission of AIDS via blood is a special circumstance that
accounts for few cases except among intravenous dmg abusers
and from mother to fetus. If a pregnant woman is infected, there
may be a 50% chance that her child will be bom infected. The
risk of transmission of AIDS via blood transfusion is very low,
probably in the range of one per 60,000 units of blood or less
with present antibody screening. Transmission of fatal viral hepatitis (usually non-A, non-B) is at least six times more frequent.
Present antibody screening and procedures to discourage highrisk donors have eliminated almost all transfusion-associated
HIV transmission. However, it must be understood that a
number of cases of AIDS among transfusion recipients will continue to occur due to infection acquired before the antibody
screening began in the spring of 1985.
Hemophiliacs represent an exception to the rarity of AIDS
transmission from blood products. The development of
lyophilized Factor VIII concentrate, which can be administered
at home, revolutionized the treatment of hemophilia and enabled
many hemophiliacs to lead normal or almost normal lives. Un-
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fortunately, the preparation of commercial Factor VIII concentrate involved the pooling of blood from enormous numbers of
donors. A severe hemophiliac using Factor Vlll concentrate at
home could be exposed in one year to the blood products of up to
200,000 individuals. Almost all severe hemophiliacs who used
large amounts of Factor VIII concentrate at home before 1985
have become infected. Since 1985, the clotting factor concentrates have been heat-treated and now are all antibody-screened
as well. There has been no documentation of transmission from
heat-treated, antibody-screened products, and transmission
from products that have been heat-treated but not antibodyscreened is extremely rare.
Certain blood products carry noriskwhatsoever of HIV transmission. These include albumin (because it is pasteurized),
immunoglobulins of all types (regular gamma globulin, HBIG,
Rho-Gam, etc), the hepatitis B vaccine, and now the heattreated, antibody-screening clotting factors. The fractionation
process involved in the preparation of immunoglobulins has
been shown to produce a 15 log reduction in the titer of HIV
vims. Since the highest titer HIV found to date in human blood
is lO'* (4 logs), this provides an enormous safety margin. Also,
steps in the preparation of the original hepatitis B vaccine (which
was made from blood) kill all HIV so there is no risk.
Although antibody to HIV is found in many lots of immune
globulins today, this has not produced even transiently positive
antibody tests in recipients of intramuscular immune globulin.
Rarely has there been transient ( ^ 30 days) weak-positive
ELISA reactivity in persons receiving high-dose intravenous
immunoglobulins.
Social contact
The Centers for Disease Control (CDC) term interaction with
family, close friends, and co-workers as "casual contact," but
actually mean intimate contact short of sexual relations. There is
overwhelming evidence that such contact virtually never transmits HIV. To date, 715 individuals who have lived in the same
household as someone carrying HIV but who are not sexual
partners of the infected person or infants bom while the mother
was infected have been studied carefully. None of these 715 people are seropositive. Since half of the household contacts in all
ofthese studies were children, the fear that school teachers with
HIV infection will transmit the virus to their students seems
totally unfounded.
Thefirstofthe household studies is an ongoing study through
Montefiore Hospital in New York City. These AIDS patients are
mostly poor, Hispanic, intravenous dmg abusers living in very
crowded conditions in New York City—certainly not an optimal
situation regarding household hygiene. A total of 199 of these
household contacts have been studied. Ninety percent of these
contacts had shared the bathroom and kitchen, 50% had dmnk
from the same glass or eaten from the same dish before it had
been washed, 30% to 40% had slept in the same bed (mostly
children sleeping with their parents) and bathed with the patient,
10% to 15% used items that might draw blood such as razors,
toothbrushes, or nail clippers, 83% kissed on the cheek, and
17% kissed on the lips. That none of these 199 nonsexual household members is seropositive is strong evidence against close
personal contact short of sexual relations transmitting HIV.
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In a second study the AIDS patients were children with transfusion-associated AIDS, most of whom shared toys with their
siblings. Again, none of 85 household contacts are seropositive.
Six different groups have looked at 269 family members of
hemophiliacs, many of whom helped to administer the intravenous Factor VIII at home to the patients, and none of these
individuals is seropositive. Also, none of the other 162 household contacts in four other studies are seropositive.
The only report of a seropositive household member involves
a case from Germany of a seropositive 6-year-old brother of a
3-year-old boy who died of transfusion-associated AIDS. The
route of that transmission is unclear. Although the author suggested a bite as a possible cause, the mother stated that the bite
did not break the skin or cause bruising. More likely another
route of transmission is possible, including blood mingling or
even childhood sexual play.
Regarding teeth bites, in prospective studies there has been no
documentation to date that bites can transmit AIDS. In the study
of children with transfusion-associated AIDS, there were 15 instances in which the patient bit a sibling or vice versa, and none
of the 15 siblings was seropositive. In another study a hemophiliac was injured in an automobile accident and suffered brain
damage which caused him to bite people. He had ARC, his
mouth was "always dripping with blood and saliva," and he bit
30 health care workers to the point of leaving scars, yet none of
these individuals is seropositive. One of our own employees
who was bitten by an ARC patient is seronegative at 15 months
after exposure.
Other methods of transmission
Organ transplantation—Organ transplantation or donation
of other body components such as semen carries a risk similar
to that of a single unit of blood. Current policy is to screen all
donors for HIV prior to organ transplantation. Thus, future
transmission via these routes should be exceedingly rare.
Breast milk—Transmission may occur through breast milk.
The one reported case involved a woman who after delivery acquired the infection from a blood transfusion. She nursed her
baby for six weeks, and the baby was subsequently found to be
infected. The vims has been isolated from breast milk on several
occasions.
Tears and saliva—The possible presence of the AIDS vims
in tears and saliva alarms the general public. What the public
ignores is that there has been no evidence of transmission by
these routes. Even though a small amount of vims may be present in tears and saliva in only a minority of infected individuals,
no evidence suggests transmission by these routes.
Other bodyfluids—Relativelylarge amounts of vims may be
present in cerebrospinal fluid and brain when the central nervous
system (CNS) is infected. This certainly could present ariskof
nosocomial transmission, although none has been reported to
date. The vims is present in small amounts in urine in a minority
of people but no transmission from this source has been documented. Cultures from feces have not yet been done because of
technical difficulties, but the virus could be present in feces.
There is no evidence of transmission from sweat.
Insects—There has been no evidence of mosquito or other insect transmission despite the theoretical possibility raised by
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certain laboratory studies. The strongest evidence against mosquito transmission is the absence of seropositivity in children
agesfiveto 15 years in Belle Glade, Florida, and central Africa
in areas where 5% to 10% of adults are infected. Children older
than five and younger than 15 years are likely to have been bom
before their mothers became infected (since there were relatively few infected heterosexuals in the United States or Africa
five years ago) and are likely to be too young to be sexually active themselves. Yet these are the very individuals who are in
closest contact with their infected parents and most likely to be
bitten by the same mosquito.

Common Misconceptions Regarding
TVansmission
The concem about insect transmission of HIV is an excellent
example of the common error made by laypersons and medical
personnel who fail to make the critical distinction between theoretical and actual routes of transmission. Anyone can dream up
a thousand different theoretical scenarios for HIV transmission.
However, one must look to the science of epidemiology, which
is the study of disease transmission, to find the ways in which the
infection is and is not really being transmitted among persons in
contact with HIV-infected individuals.
Another source of confusion and potential hysteria is the
CDC's list of AIDS cases by risk factors. At the bottom of the list
is a group called "no risk identified." The general public often
assumes that these are persons who contracted AIDS from toilet
seats, food, etc, or other as yet unrecognized means of transmission. In fact, there is no evidence that this is so. Indirect evidence suggests that most of these persons have risk factors that
they are unwilling to admit. This is understandable, given such
.sensitive subjects as homosexuality and dmg abuse. A minority
ofthese persons may have been unwittingly infected through
sexual partners who had risk factors of which they were
unaware.

Nosocomial TVansmission
Although the routes of transmission of HIV and the hepatitis
B virus are similar, fortunately the nosocomial transmissibility
of HIV is much, much less. Many health care workers are not
aware of this low risk of HIV transmission. The few instances of
transmission have been well publicized, but the denominator—
namely, how many other health care workers have been exposed
and remain uninfected—is little known by many people. The
difference between HIV and hepatitis B transmission is best exemplified by the data to date on needle sticks. In prospective
studies up to 25% of those with needle sticks from hepatitis B
carriers have seroconverted, whereas studies to date have shown
seroconversion in only one of 514 needle sticks from HIV
carriers. These are data from a compilation of five studies conducted by the CDC, National Institutes of Health, San Francisco
General Hospital, University of California-Los Angeles, and
the Communicable Disease Surveillance Centre in London
(the British equivalent of our CDC), plus six of our health care
workers who were not part of the CDC study. (Eight other Henry
Ford Hospital employees are included in the CDC data.) In these
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studies the exposures were not only needle sticks but other percutaneous exposures, such as scalpel cuts. I will use the term
needle stick to stand for all percutaneous blood exposures. Of
importance in the prospective studies was that blood was first
tested within 30 days of the needle stick, to be sure that the individual had not previously acquired HIV, and was then tested
again three months or more after the needle stick.
In addition to the one seroconversion from needle stick in the
prospective studies of 514 individuals, three other anecdotal reports of seroconversion from needle stick have been reported in
the world to date. All four of these reported seroconversions involved nurses, one each from the United States, Britain, France,
and Martinique. Two of these nurses experienced inadvertent injection of blood in addition to the needle stick. Since there is no
denominator for the three anecdotal reports, our best guess as to
the denominator, and hence the risk, for needle stick transmission is from the five prospective studies previously cited:
approximately one in 500 with a 95% confidence interval well
below 1%.
This striking difference between hepatitis B and HIV transmission from needle stick is probably due to the enormous
amount of hepatitis B vims in the blood versus the small amount
of HIV in blood: hepatitis B carriers have 10"* to 10" viral particles per mL whereas HIV carriers have 10' to 10" (usually 10' to
10^) viral particles per mL of blood.
In areas with a high incidence of HIV infection in North
America and London, prospective studies of health care workers
without risk factors in their private lives have shown only one
seropositive individual (the American nurse who had suffered a
needle stick) among the 2,499 tested. Among dental workers
(75% dentists, 60% of whom practiced in high-risk areas), only
one of 1,795 was found to be seropositive, and this case is still
under investigation to eliminate risk factors in the person's
private life. This exceedingly low incidence of seropositivity
among dentists is of particular interest since it is well known that
dentists have been at a higher risk of hepatitis B than physicians.
Individual case reports offiveother instances of transmission
through patient care have been documented in the world. These
instances apparently involved exposure of dermatitic skin to
blood in three cases, blood in the mouth in one case, and in the
last case extraordinarily poor hygiene on the part of the caregiver in the face of prolonged and intense exposure to blood and
body fluids. Three of the five instances occurred among health
care workers while on the job; in two of these instances the
health care workers were not using the recommended precautions, and in the third case a very unusual accident occurred.
The other two cases involved caregivers in the home, dealing
with persons not recognized to be infected. One of these instances involved a mother who was a paramedic and who cared
for her infant at home. The child was bom with a congenital intestinal disorder requiring colostomy and causing heavy bleeding. The infant became infected from the transfusions, which
went unrecognized for months. The mother was found to have
seroconverted at the time of blood donation. Despite being a
health care worker, the mother exercised very poor hygiene
and usually did not wash her hands for some time after getting
blood or feces on them. The other home care instance involved a
British woman with extensive eczema on her hands and arms
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who cared for an ill neighbor until he died. The diagnosis of
AIDS was unsuspected until postmortem examination.
To put the risk of these worrisome non-needle stick exposures
in perspective, we need to consider the data on: 1) mucosal exposure in prospective studies, and 2) the previously mentioned
serosurveys of health care workers. Regarding mucosal exposure to blood and body fluids, thefiveprospective studies previously mentioned also looked at such exposure and found no
seroconversions in 493 individuals. Of the 4,294 medical and
dental health care workers serosurveyed, only two were
seropositive, one of which involved a needle stick. Many of
these individuals doubtless had taken care of HIV-infected individuals without realizing it, and many probably at times had
dermatitis or breaks in the skin.
Another way of viewing the health care workerriskis to see if
health care workers are disproportionately represented among
the persons in the "no identified risk" in the United States: in
fact they are not. Health care workers make up about 5% of that
group and 5% of the US population in general. Even in Zaire
where the seropositivity rate among inpatients is very high and
where hospital hygiene is very different (eg, nurses have to wash
used needles before resterilization), the seropositivity rate
among health care workers is the same as that of the general population, around 5%. This suggests that the increase inriskmust
be very slight, even in Zaire.
What does happen in the rare instances where there is transmission to health care workers? These instances may represent
either patients who are particularly infectious (ie, those who
have a high titer of circulating virus and/or a more infectious
strain of vims) and/or health care workers who are particularly
susceptible to HIV, possibly on a genetic or general health basis,
or more likely a combination of these factors.
Regarding home care, many of the 715 household contacts
mentioned previously helped care for AIDS patients at home,
usually for some time (often years) before the diagnosis was
made, and thus no special precautions were being used. This
included many family members of hemophiliacs who helped
administer infected intravenous Factor Vlll at home.

Magnitude of the Epidemic
Over 36,000 people in the United States and about 360 individuals in Michigan as of June 1987 have had full-blown AIDS.
With estimates of 50 to 100 carriers for every case of full-blown
AIDS, we may have 2 million in the United States and at least
20,000 in Michigan who are carrying HIV infection. Among
the persons in high-risk groups, the infection rates are astronomical . Of the homosexual or bisexual men in most large urban
areas, 30% to 70% are already infected. Michigan has been fortunate in that the epidemic has been slower to spread, probably
because Detroit is not a tourist mecca. A study one year ago suggested that only about 20% of Detroit-area homosexual or bisexual men were infected. The infection rate for intravenous dmg
abusers also ranges from 30% to 70% in many East Coast urban
areas, yet is only 5% to 10% in the Detroit area. However, this is
no cause for complacency. Two other areas with large numbers
of intravenous dmg abusers per capita. New York City and (curiously enough) Italy, have had astronomical increases over a fiveyear period in infection rates in intravenous drug abusers. In
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both these areas HIV infection rates in intravenous dmg abusers
went from 5% to 10% in 1980 to 60% to 70% five years later in
1985. Thus, one can anticipate that by 1991, 60% to 70% of the
estimated 30,000 to 40,000 intravenous dmg abusers in Detroit
will be infected. This also will lead to infection in at least half of
the sexual partners, and one quarter of their babies, which
means there may be hundreds of babies with AIDS in Detroit by
1991. Among hemophiliacs, because the Factor VIII concentrate
was nationally distributed, the infection rates are the same
throughout the United States. For those using that product at
home before 1985, infection rates range from 70% to 100%.
If we had a vaccine tomorrow, we could not help many of the
people in the high-risk groups because they are already infected.
AIDS is the leading cause of death among gay men in urban
areas. Because AIDS strikes young people, it has become the
fourth leading natural cause of years of life lost in the United
States behind only cancer, heart disease, and stroke. For a disease that was unknown six years ago, this is incredible. Central
Africa faces a holocaust from this disease. In central Africa 5%
to 20% of the general population are already infected with the
vims, and public education campaigns have just started. Estimates are that there may be 5 to 10 million infected persons in
Africa already, and these rates continue to escalate rapidly. Estimates for the United States by the year 1991 include: 1) more US
citizens will have died of AIDS than have died in all the wars
since World War I , 2) in that year for the first time AIDS will kill
more people than are killed in motor-vehicle accidents, and
3) the number of infected persons in the United States could be
as high as 5 to 10 million.

Symptoms
The CDC has devLsed a classification system for HIV infection based on clinical manifestations. An outline of this system
is given in the Table (also see the Suggested Reading list, #6).
Investigators are attempting to use this system for future studies.
However, some commonly used terms such as ARC are not employed in the CDC system. In the following section commonly
used terms will be explained along with reference to the CDC
system terminology.
Persons infected with HIV may have symptoms ranging from
none to fatal. The symptoms may occur at any time after infecfion, anywhere from one week to over seven years later. An unknown percentage of persons have an acute self-limited illness
one to eight weeks after infection (CDC group 1). The acute illness may be "mono-like" with fever, myalgias, lymphadenopathy, rash (in 50%), diarrhea (in 30%), or may be neurologic
(aseptic meningitis, acute encephalitis, and Guillain-Barre syndrome have been reported). These manifestations will often
resolve when they result from initial infection and are not
to be confused with the progressive neurologic disease seen
later in the course of HIV infecrion (CDC group IV-B).
Between one-third and two-thirds of HIV-infected persons will
develop lymphadenopathy at some time after infection, which
may remain for years. This is termed persistent generalized
lymphadenopathy (PGL) in the CDC classification (CDC group
III). Lymphadenopathy will often disappear if the total number
of lymphocytes in the body gets very low, ie, just before or at the
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Table
Centers for Disease Control Classification
System for HIV Disease
CDC System Description Name
Group I
Acute infection: Within one to two
months of exposure
••Mono"-like or central nervous system
Group II
Asymptomatic
Group III
Persistent generalized lymphadenopathy (PGL)
Group IV
A. Constitutional symptoms: fever,
weight loss, diarrhea
B. Neurologic disease
C. Secondary infections;
C-I. CDC-AIDS infections
C-2. Other specified infections:
thrush, zoster, tuberculosis, hairy
leukoplakia, nocardia, recurrent
salmonella bacteremia
D. Secondary cancers:
CDC-AIDS tumors: Kaposi's sarcoma,
certain lymphomas
E. Other conditions:
infections, cancers or symptoms not in
A through D

Common Name
Acute infection
Healthy carrier
Lymphadenopathy
ARC or wasting
syndrome
ARC
AIDS
ARC

AIDS
ARC

onset of AIDS, Other nonspecific symptoms such as fever, night
sweats, weight loss, and diarrhea are common as immune function gets low, but may occur transiently in those with normal
immune function.
The term ARC (AIDS-related complex) unfortunately has no
generally agreed upon definition. Some use the term for any
clinical manifestation of HIV infection short of full-blown
AIDS, I prefer to limit that term to those with severe symptoms,
prodromal infections, or severe immune deficiency as
manifested by T-helper cell counts under 200/mm\ The term
"wasting syndrome" applies to patients with severe fever,
weight loss, and diarrhea, which inevitably leads to AIDS (CDC
group IV-A).
Certain infections, especially if recurrent, should raise the
suspicion of HIV infection (CDC group IV, C-2). These infections have been called "prodromal infections" because they
seem to carry a relatively high risk of progression to full-blown
AIDS. Thisriskmay be as high as 50% to 80% over the next one
to two years. Prodromal infections include: 1) thmsh, especially
that which occurs in adults not receiving antibiotics or that
which recurs after treatment; 2) zoster; 3) tuberculosis; 4) oral
hairy leukoplakia, a condition resembling thmsh which causes
ribbed, white lesions on the lateral tongue margins or opposing
cheek and is KOH-negative; 5) recurrent salmonella bacteremia;
and 6) nocardiosis. The latter two are much rarer. In contrast to
the onset of opportunistic infections, which is usually preceded
by some waming sign such as the wasting syndrome or thmsh,
some individuals who develop Kaposi's sarcoma are often
asymptomatic and simply notice the skin lesion. Many of them
have had lymphadenopathy.
Tuberculosis itself—ie, infection with Mycobacterium tuberculosis (not to be confused with infection due to the atypical
mycobacterium, Mycobacterium avium-intracellulare, which is
common in full-blown AIDS)—is much more frequent among

AIDS Update—Fisher

11

HIV-infected people. It may occur either before or after the
development of full-blown AIDS. Persons who were tuberculinpositive prior to the onset of HIV infection are very likely to
develop active tuberculosis as immune function declines. Since
there is a higher incidence of tuberculin positivity among urban
intravenous dmg abusers and foreign-bom persons such as Haitians, one sees a concentration of HIV-associated tuberculosis in
New York City, Newark, and Miami, and such can be anticipated in Detroit as our intravenous dmg abuser HIV-infection
rate climbs. Tuberculosis represents the one possible public
health threat of HIV infection that is airborne. Fortunately, the
tuberculosis seen is usually of low or no contagiousness since
cavitary disease is very rare. The pulmonary manifestations are
usually atypical of adult reactivation disease: forexample, hilar
lymphadenopathy and infiltrates typical of primary disease
(even though not primary) or miliary disease. Often the tuberculosis is extrapulmonary involving lymph nodes only.
The four major neurologic manifestations of HIV infection
are: 1) encephalopathy, of which the most common form is
chronic and known as AIDS dementia which affects 50% of persons with full-blown AIDS; 2) myelopathy with ataxia and
incontinence; 3) aseptic meningitis which may be chronic and
recurrent; and 4) peripheral neuropathies including acute inflammatory polyneuropathies such as mononeuritis multiplex,
distal symmetric neuropathies similar to those seen in diabetes,
or cranial neuropathies (CDC group IV-B).
HIV-infected persons often suffer from an increased incidence of common skin disorders especially as immune function
declines. These include seborrheic dermatitis (which often becomes very severe on the face in full-blown AIDS), folliculitis,
fumnculosis, acne, dry skin, dermatomycoses, and nonspecific
rashes. These skin disorders tend to be stubborn and recurrent in
HIV-infected persons.
Phenomena of immune dysregulation in HIV infection include frequent adverse drug reactions, blood cell dyscrasias
(thrombocytopenia, leukopenia, and anemia), circulating immune complexes, and lupus-like abnormalities (lupus anticoagulant, antinuclear antibodies). In fact, almost any disorder
could be a manifestation of HIV infection. Thus, we can now
say of HIV infection what was once said of syphilis: to know
AIDS is to know medicine.
The diagnosis of AIDS itself is made when a person is diagnosed as having one of the 12 opportunistic infections (CDC
group IV, C-l), two tumors (CDC group IV-D), or lymphoid interstitial pneumonia in an infant (CDC group IV, C-1), These are
the official CDC criteria for AIDS. Plans are to add to these criteria the wasting syndrome, AIDS dementia, and, in infants,
certain combinations of severe bacterial infections. It is important to reserve the term AIDS for persons meeting these criteria
since only these individuals have a prognosis that is inevitably
fatal.
Tumors named in the criteria for full-blown AIDS include not
only Kaposi's sarcoma and primary CNS lymphoma, but also
non-Hodgkin's lymphomas of high-grade B-cell types i f a
patient is seropositive. These are usually histopathologically
described as either diffuse undifferentiated, large cell, Burkitt's
orBurkitt's-like lymphoma, or immunoblastic sarcoma. The
recognition of AIDS-associated lymphomas means HIV testing
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should be perfonned on most persons with such tumor types.
Knowledge of HIV infection is critical regarding management
of the tumor and prevention of transmission, especially to sexual partners. At present, HIV lymphomas tend to be very
aggressive, and the patient will die of other manifestations of
AIDS if not the tumor itself. Therefore, the "no-treatment
option" must be offered. An extremely high incidence of opportunistic infection must be anticipated whether or not treatment
is given.
It is important to do HIV-testing on all patients with Kaposi's
sarcoma, even if they are elderly men of Jewish or Mediterranean extraction. One of the most interesting aspects of AIDS is
that the incidence of Kaposi's sarcoma is much higher in gay
men (20% to 40%) than in any other risk group (2% to 10%) or
even in Africans (16%), The manifestations of AIDS otherwise
seem very similar in all risk groups. Hypotheses for this difference in the incidence of Kaposi's sarcoma involve two possible cefaclors for Kaposi's sarcoma among gay men: the higher
use of inhaled nitrites, and the higher incidence of reexposure to
cytomegalovims via semen among gay men.

Serologic Testing
Of all people infected with HIV in the United States, at present only about 1% to 2% have full-blown AIDS. Only one-third
ofall those infected have some symptoms, signs such as obvious
lymphadenopathy, or laboratory abnormalities such as leukopenia or thrombocytopenia. The remaining two-thirds are
asymptomatic and have no obvious abnormalities on physical
examination or routine laboratory testing. The only way to detect these asymptomatic carriers is through serologic testing for
antibodies to the AIDS vims. Two methods of HI V-antibody detection are commonly used. The screening test is done by the
ELISA method, which is performed at Henry Ford Hospital and
many other large laboratories. A preliminary estimate of the
likelihood of a positive ELISA being a tme positive can be made
from how strong a positive it is. In our laboratory if the sample/
cut-off ratio is greater than five, this is a strong positive and is
very likely to be a true positive. The Western blot method of
antibody detection is used as the backup or "confirmatory" test.
The Westem blot is much more difficult and expensive and is
done only by a few reference laboratories. In Michigan it is done
by the Michigan Department of Public Health in Lansing, and
results take four to six weeks. The ELISA and Westem blot can
be thought of as roughly similar to the VDRL and the specific
treponemal tests (such as FTA) for syphilis testing. However, the
sensitivity and specificity of the ELISA is much higher than that
of the VDRL, ranging from 95% to 99%.
The blood test for HIV antibodies is unlike any other test that
a physician orders. This test should never be ordered without the
patient's consent, except under the most extreme circumstances,
because a positive result is a catastrophic event in the person's
life. It is more devastating than a test for cancer or any other potentially fatal disease because no other disease carries the stigma
that HIV infection carries. Persons have committed suicide as a
result of this test, and any patient faces potential abandonment
by family, friends, lover, as well as loss of job and insurance. It
is absolutely essential that the physician determines the patient's
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psychological support system before ordering the test. If the patient says there is no one with whom he or she can discuss the
test result—ie, no family, friend, pastor, volunteer support
group, or professional counselor—it is best to defer testing until
support is available. In the meantime the patient is advised to
behave as if he or she is positive. Before testing, all patients
must be counseled about the limitation of antibody methods:
I) false-positives and false-negatives; 2) that even though the
presence of antibodies does not prove that the infectious agent is
present, it must be assumed that any antibody-positive person is
presently carrying HIV; and 3) that antibody positivity gives no
information about the duration of infection or prognosis. The
patient must be counseled about the civil rights issues, particularly regarding homosexuality. Most heterosexuals are unaware
that in Michigan homosexuals can lose their jobs and be refused
housing just because they are homosexual. Although it is illegal
to discriminate on the basis of race, sex, or religion, discrimination based on sexual preference is not illegal except in three cities in Michigan (Detroit, Ann Arbor, and East Lansing), which
have local ordinances prohibiting such discrimination. Thus,
known homosexuals can be fired whether or not they are HIVpositive, Moreover, since medical confidentiality is at best a
loose term, a person known to his/her friends or co-workers as
antibody-positive may become an instant leper Some protection
is offered in that the Michigan Department of Civil Rights has
declared HIV infection a handicap. Nevertheless, attempts have
been made to fire or refuse employment to HIV-positive persons. Because of these concems, patients should be made aware
that a number of alternate test sites offer anonymous testing.
Patients may call Wellness Networks, our local AIDS organization, to obtain the locations. The Wellness Networks telephone
number is toll-free (1-800-872-AIDS) throughout Michigan, At
the altemate test sites, pretest and posttest counseling is given,
the results do not go into the patients' medical records, and results are not given until the Westem blot test result is received.
Anonymous screening is often the best option for persons concemed about confidentiality, including heterosexuals at a low
risk of HIV disease. For the latter, a positive ELISA test is usually going to be a false-positive. With anonymous testing the
false-positive ELISA does not become part of the patient's
permanent medical record (and thus a subject of misinterpretafion indefinitely).
The predictive value of a test, that is, the likelihood that a
positive is a tme positive and a negative is a tme negative, is a
particularly critical issue regarding HIV testing. The formula
used to calculate predictive value (Bayes' theorem) contains a
critical third variable in addition to the sensitivity and specificity
ofthe test. The critical third variable is the estimated prevalence
of the disease in the population being tested. There is no way
around the fact that the predictive value of a positive test will be
low in a low-risk group, no matter how good the test is. For this
reason screening of low-risk people on a large scale is not generally recommended unless they are going to be donating body
parts to other individuals. On the other hand, the predictive
value of a positive result is very high in high-risk groups, but in
those groups the predictive value of a negative is somewhat
lower In fact, it is best to suggest that persons who have been on
the receiving end of anal semen from a known infected person
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assume that they are positive indefinitely even though their
screening test may be negative.

Management of Seropositive Persons
What should we tell people whose test results (both ELISA
and Westem blot) seem to be tmly seropositive? Experimental
studies indicate that the majority of these people are still infected and will likely remain so for life. Moreover, the sensitivity of our current culturing and antigen-detection methods
(all of which are experimental at present) is suspected to be
rather low. Latently infected cells could start producing infectious vims at any time. Thus, we have to assume that anyone
who has ever been infected is still infected. No one knows why
some persons will develop the fatal disease while others do not.
In terms of predicting the likelihood of development of AIDS,
time appears to be a major factor The longer a person has had
the infection, the greater theriskthey will progress to full-blown
AIDS. Certain prodromal infections such as thmsh, zoster, and
tuberculosis indicate a higher risk of progression. The single
laboratory parameter that most closely correlates with theriskof
AIDS is the absolute number of T-helper cells. The T-helper (or
T4) lymphocyte is the key cell in the immune system. Normal
numbers are 400 to 1700 per (JLL. Persons with less than 400
T-helper cells are at steadily increasing risk. Opportunistic infections become likely when the helper cell count reaches 200 or
less, although some individuals can go a year or two at these
levels without developing AIDS. On the other hand, Kaposi's
sarcoma can develop with higher, occasionally even normal,
numbers of T-helper cells. The T-helper-suppressor ratio
appears not to be as important as the number of helper cells.
However, there is some evidence that persons with very large
numbers of suppressor (T8) lymphocytes (which results in a
disproportionate lowering of the ratio) may be at greater risk.
Usually full-blown AIDS does not develop without premonitory
clinical or laboratory deterioration. If patients who are HIVseropositive are followed, a progressive decline is seen in the
number of T-helper cells in many of these individuals over a
period of time, and the physician can then inform the patient
when the risk of AIDS becomes significant. Knowing the
T-helper cell count is clinically useful in other ways also: for example, a seropositive individual with cough and fever and 500
T-helper cells is very unlikely to have Pneumocystis pneumonia
whereas someone with similar symptoms and 150 T-helper cells
is very likely to have Pneumocystis pneumonia.
Another recently described predictive factor for high risk of
AIDS over the succeeding one to two years is the appearance of
circulating antigen to the core ofthe vims (p24 antigen) and disappearance of antibody to the core (p24 antibody). Assays for
p24 antigen and antibody will soon be on the market.
Based on experience with other infections, certain conditions
that contribute to a poor general state of health may make a person more susceptible to HIV. In addition, acceleration of HIV
disease may result from repeated reexposure to other long-lasting viral infections such as cytomegalovims, Epstein-Barr
vims, and the viral hepatitides. In vitro, these vimses produce
long-lasting activation of the T-helper cells, which makes these
cells much more susceptible to infection with the HIV virus.
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Persons with many sexual partners or repeated blood exposure
have a much higher rate of reexposure to these ubiquitous viral
agents. Certain proteins of these other vimses may "tum on"
HIV. These proteins mimic the tat gene of HIV, which accelerates HIV replication.

Medical Management of Seropositive Persons
Seropositive individuals are seen for an initial evaluation. A
history, physical examination, and the following tests are done:
complete blood count with differential, sedimentation rate,
platelets, and SMAC; urinalysis; helper/suppressor counts; skin
tests for tuberculosis, histoplasmosis, coccidioidmycosis,
and two controls; serology for toxoplasma, hepatitis B (including core antibody), herpes viruses (herpes simplex,
cytomegalovims, Epstein-Barr vims, and varicella-zoster), and
syphilis (including VDRL and a treponemal test); and chest
x-ray (particularly to rule out hilar adenopathy and tuberculosis). The skin tests and serologies serve to indicate infections to which a person may have been exposed in the past that
can reactivate if the immune functions decline. These tests are
more reliable if done when immune function is good. When immune function declines, most persons become anergic and antibody tests may become negative. Indicated vaccines and INH
prophylaxis, if tuberculin positive, are offered. Follow-up is
every six months if persons are feeling well and have normal
numbers of T-helper cells; follow-up is every three months if
persons are symptomatic or have low numbers of T-helper cells.
At each visit a history and brief physical examination (with special attention to mouth, skin, lymph nodes, and spleen) are
done. Laboratory studies include complete blood count with differential, sedimentation rate, and helper/suppressor counts.
Presently zidovudine (formerly known as AZT) is available to
persons with ARC with less than 200 helper cells. This is another good reason for persons at risk to be tested and followed,
since some persons with less than 200 helper cells are
asymptomatic and may be passing up an opportunity for lifeprolonging medication.
Advice to seropositive persons is as follows:
1, Maintain the best possible state of health. Get good nutrition, exercise, and adequate rest; reduce or eliminate drugs,
cigarettes, and alcohol; and manage stress. Of these, stress management is often the most difficult. Persons who are seropositive
without AIDS are actually under greater stress than persons with
AIDS because of the uncertainty of their position. The feeling of
carrying a time bomb is poorly tolerated by human beings.
Many persons can benefit from professional counseling or
volunteer support groups such as those run by Wellness
Networks, Inc.
2, Use safe sex precautions. These precautions not only protect others but also the patient from acquisition of more HIV
(which may not be helpful) and from reexposure to other vimses
such as cytomegalovims, herpes simplex, Epstein-Barr vims,
and hepatitis B, which could accelerate the HIV process. Safe
sex should be implemented even when both partners
are seropositive.
3, Take indicated vaccines. These include vaccines for pneumococcus, influenza, hemophilus type B in children and hepati-
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tis B for those individuals who are hepatitis-B-seronegative.
Salk inactivated polio vaccine and diphtheria-tetanus toxoid are
also safe. Live viral vaccines should be avoided: yellow fever,
oral polio, and measles, mumps, and mbella. The only exception is asymptomatic seropositive children with normal immune
functions who may do better with these live viral childhood vaccines, since to date no adverse complications have
been reported.
4. Get regular checkups. This also enables the individual to
be alert to the possible availability of antiviral or immune stimulant therapy in the future.

Prevention
The health care setting
Blood and body fluid precautions, the same as for hepatitis B,
are recommended. This involves the use of gloves for drawing
blood and touching mucous membranes or open sores. Gloves
are all that are needed in most routine clinic visit settings. If
there is a good possibility of aerosolization of blood, urine,
feces, exudates, or respiratory secretion or saliva that contain
observable (visible) amounts of blood, then full garb with mask,
gown, gloves, and eye protection is indicated. These situations
are likely during certain dental or endoscopy procedures,
surgery, autopsies, and occasionally suctioning. If soiling of
clothes with blood, exudates, urine, or feces is likely during examinations or nursing care, gowns are indicated. Many needle
sticks are a result of recapping. Therefore, the most important
measure in preventing needle sticks is the placement of impervious needle containers in every inpatient room and clinic examination room.
The AIDS vims is readily killed by all common disinfectants,
most rapidly by chlorine. It is likely that even soap and water
effectively inactivate the virus with regard to transmission
potential, ie, reduce the amount of vims to such low levels that
transmission is not possible. No evidence suggests transmission
from environmental surfaces. Although all viral particles do not
die immediately on exposure to air (the titer decreases about I
log every nine hours and the usual amount of vims in body fluids
i s « I to 2 logs), there is too little virus present on environmental
services to be effectively transmitted. Often quoted laboratory
studies which show prolonged survival of the vims on environmental surfaces are unrealistic, since the amount of vims used
was much larger (eg, 7 logs) than that found in nature. If blood
splashes on a person, the most important action is to wash it off
promptly. What is used to wash it off is not critical. If blood
splashes in the eye, the eye should be rinsed with copious
amounts of water.
The aim of the Michigan Society for Infection Control and the
Michigan State Medical Society Task Force on AIDS education
is to get health care providers to gradually phase into "Universal
Blood Precautions." This means the use of such precautions for
all patients regardless of whether they are known carriers of HIV
or hepatitis B, Any other policy is unrealistic if we are trying to
prevent as many blood-borne infections as possible. The approach of testing all hospital admissions or clinic patients for
HIV (or hepatitis B) is a naive one, although such an approach is
the desire of many physicians these days. This approach ignores
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several important realities: 1) testing misses some HIV-infected
persons, especially within the first one to three months after infection (and physicians are also poor at guessing which patients
are likely to be in high-risk groups); 2) HIV testing of all hospital admissions would be very costly (the estimate for Michigan
alone is $35 million per year); 3) it is extremely likely that there
are other serious blood-bome infections of which we are not yet
aware; and 4) testing frequendy leads to situations where health
care workers are overly cautious with certain patients and careless with other patients—in other words, testing can lead to a
false sense of security. It is much better to tighten up technique
overall and to have a healthy respect for all blood and body
fluids. Any other approach is naive and unrealistic.
Home precautions
Good hygiene is the principle precautionary measure. Items
that might draw blood (eg, razor, toothbmsh, nail clippers, enema equipment) should not be shared. Spills of blood and body
fluid should be cleaned up promptly. A one-tenth solution of
household bleach or other disinfectant such as Lysol is most effective. Disposable gloves are desirable for handling blood and
body waste. If gloves are unavailable, emphasis should be on
washing hands promptly if they become contaminated. In general, dishes and clothes can be washed in hot soapy water; bleach
is not necessary. Household members should be informed of the
results of studies on household transmission: none of 715 household members were infected, even when no special precautions
were used. This indicates an extremely low risk of household
transmission.
Intravenous drug abuse
We need many more dmg treatment facilities, since waiting
lists for dmg programs are weeks to months. If persons cannot
stop using dmgs, they should not share needles or other "works"
(such as "cookers"). If they cannot stop sharing "works," they
should be taught to clean them with alcohol or a 1:10 dilution of
household bleach. Intensive public information campaigns
should be addressed to the sexual partners of dmg users, promoting use of condoms and avoidance of pregnancy if one has a
seropositive partner.
Sexual precautions
The following are our current best guesses as to the risk of
each sexual activity:
1. 100% safe: 1) self-masturbation, and 2) mutually monogamous relationship since 1977 with partner who is not infected.
2. Probably safe: 1) Mutual masturbation (if no open sores on
hands or genitals; if so, use disposable gloves), and 2) kissing of
non-oral, non-anogenital areas of body (ie, kissing erogenous
zone where there is intact skin such as ears, neck, breasts, etc).
3. Possibly safe: sexual kissing (ie, tongue-to-tongue
kissing).
4. Very low risk: 1) fellatio with condoms, and 2) cunnilingus
using dental dam (a piece of mbber that is held over the vulva, an
activity which most persons find very awkward).
5. Low risk: 1) vaginal or anal coitus using condom and nonoxynol-9-containing spermicide (as backup in case of condom
breakage), 2) fellatio without ejaculation, and 3) cunnilingus.
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6. Low-intermediate risk: fellatio with ejaculation and without condom.
7, High risk: Unprotected vaginal or anal coitus.
No transmission has yet been documented from sexual
kissing. Nevertheless, some concern remains especially for
long-term heavy exposure as occasionally there may be small
amounts of blood in saliva. Couples where one partner is infected can be counseled to minimize tongue-to-tongue kissing
and spend more time kissing erogenous zones where there is
intact skin.
HIV does not pass through latex condoms (natural skin condoms may occasionally leak). Ideally, condoms should be 100%
protective. In actuality the failure rate with condom use for pregnancy is about 10% per year and is probably of similar magnitude for HIV. The reasons for failure are mechanical. Patients
must be educated to condom use so these errors can be avoided.
If meticulously used, condoms should be extremely protective.
The reasons for condom failure include the following:
1, Failure to use condoms properly (eg, not putting them on
until just before ejaculation, their coming off due to failure to
hold them on during withdrawal, or failure to withdraw before
erection subsides),
2, Breakage (due to poor quality, deterioration from heat and
age or use of oil-based lubricant such as Vaseline; attempts
to reuse same condom; failure to eliminate air pockets under
condom after putting it on; or failure to allow a space at the tip
for ejaculation).
3, Failure to use them on all occasions.
The spermicide nonoxynol-9 kills HIV and many other sexually transmitted pathogens in the test tube. It is the main ingredient in most over-the-counter contraceptive foams, creams, and
suppositories marketed for women and in some lubricants now
being marketed for gay men. Concentrations of 1% should be
adequate. Use of the spermicide provides some backup in case
of condom failure. Some condoms are coated on the outside
with spermicide, but it is advisable to use more spermicide.
Spermicide should be inserted in generous amounts in the vagina or anus. A small amount of spermicide should be placed in
the tip of the condom: enough to spread over the penile head but
not so much that it oozes up the penile shaft causing the condom
to slip off. The presence of spermicide on the inside of the condom tip has been shown to offer additional protection in case of
condom breakage.
Physicians must strongly encourage celibacy or mutually
monogamous relationships. Yet, at the same time, physicians
must acknowledge the realities of sexuality, that most people in
our society have at times had premarital, nonmarital, or extramarital sexual relations. Unless the physician feels that death is
an appropriate punishment for such activities, the physician
must help patients leam how to make sex safer. Society must
work toward a mutual attitude that persons who have coitus outside of safe, mutually monogamous relationships without using
condoms are regarded as careless persons who care little for
their own health and less for the health of others. The biggest
challenge is instilling this attitude in our young people, who traditionally see themselves as invulnerable and immortal. Condom ads on television may be distasteful to many people, but
most people would find it more distasteful to see their children
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or grandchildren get AIDS, The widespread use of condoms
will have significant benefits in other areas, particularly in the
reduction of other sexually transmitted diseases and unwanted
pregnancies. Given the realities of human sexuality, the condom
is our most important weapon in the fight against AIDS,
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